Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
35,330,537
-
Share change
-
+795,178
-
Total reported value
-
$1,713,563,419
-
Put/Call ratio
-
30%
-
Price per share
-
$48.53
-
Number of holders
-
276
-
Value change
-
+$41,888,246
-
Number of buys
-
134
-
Number of sells
-
127
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2024
As of 30 Sep 2024,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
276 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,330,537 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, TD Asset Management Inc, FEDERATED HERMES, INC., NEUBERGER BERMAN GROUP LLC, STATE STREET CORP, FULLER & THALER ASSET MANAGEMENT, INC., Epoch Investment Partners, Inc., DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
276
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.